To include your compound in the COVID-19 Resource Center, submit it here.

Aiming horizontal

SciBac uses horizontal gene transfer to engineer therapeutic bacteria

SciBac Inc. is using old-school genetics to make therapeutic bacteria that can battle pathogenic organisms and antibiotic-resistant infections. The approach uses horizontal gene transfer to move therapeutic genes from newly discovered species into strains already deemed safe for humans by FDA.

According to CEO Jeanette Mucha, SciBac’s DRIVE (directed recombination by in vitro evolution) platform can take any phenotype from one microbe and transfer it into

Read the full 667 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers